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Three missense SURF1 mutations identified in patients with Leigh syndrome (LS) were evaluated in the
yeast homolog Shy1 protein. Introduction of two of the Leigh mutations, F249T and Y344D, in Shy1 failed to
significantly attenuate the function of Shy1 in cytochrome c oxidase (CcO) biogenesis as seen with the human
mutations. In contrast, a G137E substitution in Shy1 results in a nonfunctional protein conferring a CcO
deficiency. The G137E Shy1 mutant phenocopied shy1⌬ cells in impaired Cox1 hemylation and low mitochondrial copper. A genetic screen for allele-specific suppressors of the G137E Shy1 mutant revealed Coa2, Cox10,
and a novel factor designated Coa4. Coa2 and Cox10 are previously characterized CcO assembly factors. Coa4
is a twin CX9C motif mitochondrial protein localized in the intermembrane space and associated with the inner
membrane. Cells lacking Coa4 are depressed in CcO activity but show no impairment in Cox1 maturation or
formation of the Shy1-stabilized Cox1 assembly intermediate. To glean insights into the functional role of Coa4
in CcO biogenesis, an unbiased suppressor screen of coa4⌬ cells was conducted. Respiratory function of coa4⌬
cells was restored by the overexpression of CYC1 encoding cytochrome c. Cyc1 is known to be important at an
ill-defined step in the assembly and/or stability of CcO. This new link to Coa4 may begin to further elucidate
the role of Cyc1 in CcO biogenesis.
fibroblasts, consists of Cox1 in association with two nuclear
CcO subunits, CoxIV and Va (38, 45, 47). A similar stalled
assembly intermediate accumulates in CcO-deficient patients
with mutations in two other assembly factors, SCO1 and SCO2.
These assembly proteins function in the maturation of the
mitochondrially encoded Cox2 subunit and the binuclear copper (CuA) site within this subunit. In contrast, studies with
patient fibroblasts harboring mutations in the genes encoding
Cox10 and Cox15 proteins, which are involved in the biosynthesis of the heme a cofactor used exclusively by CcO (at the
heme a and heme a3:CuB sites), show only free Cox1 by BN
analysis (1, 2). These data suggest that CcO biogenesis commences with the mitochondrial synthesis and maturation of
Cox1, while the other two mitochondrially encoded subunits,
Cox2 and Cox3, are added at later stages. The absence of the
S2 intermediate in cells with mutations in COX10 or COX15 is
consistent with the prediction that the S2 assembly intermediate contains Cox1 with at least the heme a center formed.
The first major clue to the function of SURF1 came from
studies with the bacterium Rhodobacter sphaeroides, in which
surf1 mutant cells showed impairment in the formation of the
heme a3:CuB bimetallic center within Cox1 (33). Specifically,
heme a and CuB were observed spectroscopically with surf1
mutant cells, but heme a3 was not present. The CuB site had an
altered spectroscopic signature to compensate for the loss of
heme a3, as the two cofactors typically coordinate with each
other. This study suggests Surf1 is involved in the maturation
of the heme a3 site in CcO. In lower eukaryotes, impairment of
CcO assembly results in proteolytic degradation of the stalled
intermediates (16). Thus, it is not possible to isolate the CcO
complex in shy1⌬ yeast cells to identify any missing cofactors.
However, Shy1 was shown to have a key role in formation of
the heterobimetallic CuB:heme a3 center in yeast Cox1 (18).

Leigh syndrome (LS) is a highly progressive neurological
disorder of infancy characterized by necrotizing lesions in the
midbrain and brain stem (32). Humans afflicted with LS have
compromised oxidative phosphorylation (OXPHOS) function
due to mutations in nuclear or mitochondrial genes encoding
respiratory chain components or their assembly factors. Although LS infants are born with a normal appearance, neurological lesions develop within months and dysfunction extends
to other organs, resulting in a high mortality rate. LS patients
typically have mutations affecting complex I or complex IV
(cytochrome c oxidase [CcO]) of the OXPHOS pathway (14).
Patients with a specific CcO deficiency most often have mutations in the SURF1 gene that encodes a CcO assembly factor
(9, 15, 41).
SURF1 is not absolutely required for CcO biogenesis in
humans, since SURF1-deficient patient fibroblasts retain 10 to
15% of residual CcO activity (32). The yeast homolog of
SURF1 is Shy1 (SURF1 homolog in yeast) and has a conserved function in CcO biogenesis (24). Yeast lacking Shy1
retain residual CcO activity, but growth of the mutant strain is
compromised on respiratory, nonfermentable carbon sources
(4).
Insights into the function of SURF1 in human cells have
been gleaned through the characterization of stalled CcO assembly intermediates in cells isolated from SURF1 LS patients
using blue native (BN) gel electrophoresis. One intermediate,
designated S2, which accumulates in SURF1-deficient patient
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TABLE 1. Yeast strains used in this work
Strain

Reference
or source

Genotype

W303
shy1⌬ mutant
coa4⌬ mutant
coa4⌬ shy1⌬ mutant
cyc1⌬ cyc7⌬ mutant

MATa
MATa
MATa
MATa
MATa

BY4741
cox11⌬ mutant
cox11⌬ shy1⌬ mutant

MATa his3⌬1 leu2⌬0 met15⌬0 ura3⌬0
MATa his3⌬1 leu2⌬0 met15⌬0 ura3⌬0 cox11⌬::kanMX4
MATa his3⌬1 leu2⌬0 met15⌬0 ura3⌬0 cox11⌬::kanMX4 shy1⌬::URA3

Invitrogen
Invitrogen
30

BY4743
shy1⌬ mutant

MATa/␣ his3⌬1/his3⌬1 leu2⌬0/leu2⌬0 met15⌬0/MET15 ura3⌬0/ura3⌬0 lys2⌬0/LYS2
MATa/␣ his3⌬1/his3⌬1 leu2⌬0/leu2⌬0 met15⌬0/MET15 ura3⌬0/ura3⌬0 lys2⌬0/LYS2
shy1⌬::kanMX4/shy1⌬::kanMX4
MATa/␣ his3⌬1/his3⌬1 leu2⌬0/leu2⌬0 met15⌬0/MET15 ura3⌬0/ura3⌬0 lys2⌬0/LYS2
coa4⌬::kanMX4/coa4⌬::kanMX4

Invitrogen
Invitrogen

coa4⌬ mutant
DY5113
SHY1-13Myc mutant
SHY1-13Myc coa4⌬ mutant
COA4-13Myc mutant

MATa
MATa
MATa
MATa

ade2-1
ade2-1
ade2-1
ade2-1
ade2-1

ade2-1
ade2-1
ade2-1
ade2-1

his3-1,15
his3-1,15
his3-1,15
his3-1,15
his3-1,15

his3-1,15
his3-1,15
his3-1,15
his3-1,15

leu2-3,112
leu2-3,112
leu2-3,112
leu2-3,112
leu2-3,112

leu2-3,112
leu2-3,112
leu2-3,112
leu2-3,112

Furthermore, it was recently shown that Surf1 in bacteria is a
heme-binding protein (10), although these findings have yet to
be confirmed in eukaryotes.
Additional insights into the function of SURF1/Shy1 came
from the isolation of genetic suppressors of shy1⌬ respiratory
deficiency in yeast (3). Respiratory function can be partially
restored in shy1⌬ cells by enhancing Cox1 translation through
the overexpression of MSS51 (6), a dual-function protein that
acts as a COX1 translational activator in addition to binding to
the newly synthesized Cox1 polypeptide. Suppression of the
shy1⌬ respiratory defect is also observed with enhanced expression levels of the two CcO subunits Cox5a and Cox6 corresponding to the human S2-containing subunits CoxIV and
Va (15). Overexpression of COA2, a recently identified CcO
assembly factor shown to interact with Shy1, can also suppress
the shy1⌬ respiratory defect (30). Finally, overexpression of
the COX10 gene that encodes the hydroxyfarnesyl transferase,
which generates heme o as the first step in heme a biosynthesis,
can partially restore respiratory function in shy1⌬ cells. Although overexpression of COX10 has only very weak suppressor activity, a marked synergistic effect was apparent in the
overexpression of both MSS51 and COX10 (29).
Shy1 has a secondary function in yeast in the maintenance of
the conserved mitochondrial copper storage pool that is used
in the copper metallation of Cox1 and Cox2 during CcO biogenesis. Yeast cells lacking Shy1 contain mitochondria with a
partially depleted matrix copper storage pool, and the respiratory defect of shy1⌬ cells can be partially reversed by growth in
the presence of exogenous copper (29). Similarly, liver and
muscle samples from patients with SURF1 mutations exhibit a
cellular copper deficiency (37). Maintenance of the matrix
copper pool is postulated to be linked to active CcO biogenesis
in general, as patient tissue with mutations to two other CcO
assembly factors, SCO1 and SCO2, result in a cellular copper
deficiency as well (22).
Human SURF1 and yeast Shy1 are both mitochondrial proteins tethered to the inner membrane (IM) by two transmem-

trp1-1
trp1-1
trp1-1
trp1-1
trp1-1

trp1⌬
trp1⌬
trp1⌬
trp1⌬

ura3-1
ura3-1
ura3-1
ura3-1
ura3-1

shy1⌬::URA3
coa4⌬::KanMX4
coa4⌬::KanMX4 shy1⌬::URA3
cyc1⌬::URA3 cyc7⌬:TRP1

ura3-1
ura3-1 SHY1-13Myc::TRP1
ura3-1 SHY1-13Myc::TRP1 coa4⌬::KanMX4
ura3-1 COA4-13Myc::KanMX4

24
This study
This study
5

Invitrogen

30
This study
This study

brane (TM) helices with a large central domain projecting into
the intermembrane space (IMS). Most LS patients with
SURF1 mutations have gene deletions or rearrangements.
Missense mutations in SURF1 are quite rare, with only a
limited number being reported. These mutations tend to be
associated with a mild clinical phenotype, and patient survival
is prolonged (28). We selected a subset of known missense
mutations, two of which lie within the IMS globular domain
and a third that maps to the second TM domain. In an attempt
to gain further insights into which functional step of SURF1
was compromised by the missense mutations, we engineered
and characterized the corresponding mutations in conserved
residues of yeast SHY1. In doing so, we have additionally
identified a new member of the CcO assembly factor family,
Coa4, that may be linked to the role of cytochrome c in CcO
assembly. We show that the respiratory defect of cells lacking
Coa4 is specifically suppressed by the overexpression of the
IMS electron carrier cytochrome c (CYC1). This is the first
time CYC1 has been found as a suppressor of a CcO assembly
mutant.

MATERIALS AND METHODS
Yeast strains and vectors. The Saccharomyces cerevisiae strains used in this
study are summarized in Table 1. The SHY1 open reading frame (ORF) was
cloned into plasmids pRS413 and pRS423 under the control of its own promoter
and terminator (450 base pairs upstream and downstream of the ORF). The
G137E, F249T, and Y344D mutations were made in both the high- and low-copy
vectors using site-directed mutagenesis. The SHY1 ORF with a 3⬘-13Myc tag was
cloned from genomic DNA of the DY5113 SHY1-13Myc strain into pRS416 and
pRS426 vectors under the control of its own promoter and the ADH1 terminator.
The G137E, F249T, and Y344D mutations were generated in these vectors by
site-directed mutagenesis. The YLR218c/COA4 ORF was cloned into a pRS425
vector under the control of its own promoter and terminator, and the COA4-Myc
insert was generated by PCR and cloned into pRS425 under the control of the
MET25 promoter and CYC1 terminator. The CYC1 and CYC7 ORFs were
amplified by PCR and cloned into pRS425 under the control of their own
promoter and terminator. The substitutions of the K78, K79, K92, and K93
residues with Glu in CYC1 were introduced by site-directed mutagenesis. Sequencing was used to confirm all cloning and site-directed mutagenesis products
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in the vectors created. The COA2 and COX10 vectors used in this study, as well
as the construction of the high-copy-number library, have all been described
previously (19, 29, 30). Yeast strains were transformed using lithium acetate.
Culture conditions for the yeast strains were either rich (YP) medium or synthetic complete (SC) medium lacking the appropriate nutrients for plasmid
selection.
Suppressor screens. For screening of the SHY1(G137E)-dependent high-copynumber suppressor, the BY4743 shy1⌬ cells containing a single-copy pRS413SHY1(G137E) were transformed with the coa1⌬ genomic DNA library (19, 29,
30). Transformants were replica plated onto the minimal selective plates containing 2% glycerol-lactate as a carbon source and incubated for 6 days at 30°C.
To confirm the dependence of the selected respiratory-competent clones on the
mutant form of SHY1, the colonies were grown in the medium supplemented
with histidine to eliminate pRS413-SHY1(G137E). Plasmids were rescued from
35 transformants, showing strong dependence on SHY1(G137E), and further
analyzed by DNA sequencing.
For screening of the high-copy-number suppressor of the coa4⌬ allele, a
genomic DNA library generated from coa2⌬ cells was transformed into BY4743
coa4⌬ cells. About 56,000 transformants were obtained, replica plated onto the
minimal selective plates containing 2% gylcerol-lactate as a carbon source, and
incubated for 4 days at room temperature. The plasmids were shed on the plates
containing 5-fluoroorotic acid (5-FOA) to ensure that the revealed suppressors
were vector borne. Plasmids were rescued from the cells showing a vectordependent respiratory growth and subjected to DNA sequencing.
Mitochondrial purification and assays. Intact mitochondria were isolated
from yeast as previously described (13). The standard Bradford assay was used to
determine total mitochondrial protein concentration (8). CcO activity was assessed by monitoring the oxidation of reduced cytochrome c (12). The specific
activity of CcO was normalized to mitochondrial protein levels and is presented
as a percentage of the wild type (WT). Metals were quantified in isolated
mitochondria using a Perkin-Elmer Optima inductively coupled plasma optical
emission spectrometer (ICP-OES) after nitric acid digestion at 95°C. A standard
curve was determined from commercially available standards (Perkin-Elmer),
and buffer samples were run in parallel as a control. All values were normalized
to milligrams of mitochondrial protein used in the analysis. In vivo mitochondrial
translation assays were conducted as described previously (30).
Localization experiments. Cells were fractionated, and the cytosolic and mitochondrial fractions collected as described previously (13). Purified mitochondria were either diluted in 20 mM HEPES, pH 7.4, or treated with 100 mM
sodium carbonate (pH 11.5) and fractionated by high-speed centrifugation (30).
The supernatant and pellet were analyzed by immunoblotting for each treatment.
The proteinase K assay was performed with isolated mitochondria incubated in
isotonic (0.8 M sorbitol, 20 mM HEPES, pH 7.4) and hypotonic buffer (20 mM
HEPES, pH 7.4) in the presence or absence of an indicated amount of NaCl for
20 min on ice (13). The treated organelles were collected by centrifugation,
resuspended in isotonic buffer, and incubated on ice for 20 min in the presence
or absence of proteinase K (0.1 mg/ml). Following centrifugation, the pellets
were loaded onto SDS-PAGE, and proteins were detected in the pellet by
immunoblotting.
BN-PAGE. Blue native PAGE (BN-PAGE) was performed essentially as described previously (46), with 1% digitonin or 1% n-dodecyl ␤-D-maltoside
(DDM). After incubation on ice for 15 min and centrifugation (20,000 ⫻ g for 15
min at 2°C), supernatants were mixed with sample buffer (5% Coomassie brilliant blue G250, 0.5 M 6-aminocaproic acid, pH 7.0) and then loaded onto a 5 to
13% gradient polyacrylamide gel. Separated complexes were detected by immunoblotting on polyvinylidene difluoride (PVDF) membrane. The high-massmarker proteins were obtained from GE Healthcare.
Immunoblotting. Mitochondrial protein samples were separated on 15% polyacrylamide gels and transferred to nitrocellulose. Proteins were visualized using
enhanced chemiluminescence (ECL) reagents with horseradish peroxidase-conjugated secondary antibodies. The anti-Myc antibody was purchased from
Roche; anti-Por1 and anti-Pgk1 were purchased from Molecular Probes; and
anti-Cox1, Cox2, and Cox3 were purchased from Mitosciences. Alex Tzagoloff
generously provided antiserum to F1 ATP synthase Atp2 and Cyc1, Carla
Koehler kindly provided Cyt1, Cyc1, and Cyb2 antibodies, the Sod2 antibody was
a gift from Val Culotta, Bernard Trumpower provided anti-Rip1, and Jerry
Kaplan provided anti-Aco1.
Additional assays. The respiratory competency of strains was determined by
growth tests on plates containing 2% glucose or 2% glycerol-2% lactate as a
carbon source. Yeast cells were grown overnight in liquid cultures in selective
medium containing 2% raffinose-0.2% glucose, adjusted to an optical density at
600 nm (OD600) of 0.5, and serial dilutions were spotted onto the plates and
incubated at 30°C or 37°C for 2 days (glucose plates) or 4 to 6 days (glycerol-
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lactate plates). The oxygen consumption of cells grown to stationary phase was
determined using a 5300A biological oxygen monitor (Yellow Springs Instrument
Co.). The rate of oxygen consumption (%O2/s/OD600) was calculated from the
linear response (17). Sensitivity of yeast strains to hydrogen peroxide was determined as previously described (19). For heme staining, mitochondrial proteins
were solubilized in 1⫻ SDS-Laemmli buffer containing 0.1 M dithiothreitol
(DTT) and resolved on 12% SDS-PAGE gels. Total protein was visualized with
Coomassie brilliant blue G250; peroxidase staining for heme detection of Cyc1
and Cyc7 was performed as described using the 3,3⬘,5,5⬘-tetramethylbenzidine
(TMBZ)/H2O2 procedure (40).

RESULTS
Characterization of human SURF1 missense mutations in
the yeast Shy1 protein. Missense mutations in SURF1 are very
rare, with only a limited number being reported (28). We
selected three known missense mutations in SURF1 LS patients that result in G124E, I246T, and Y274D substitutions in
SURF1 (31, 39). Gly124 and Tyr274 are conserved residues in
SURF1 orthologs, whereas Ile246 is a conserved hydrophobic
residue. Gly124 and Ile246 map to the IMS globular domain of
SURF1, whereas Tyr274 is predicted to exist within the second
TM domain (Fig. 1A and B).
We introduced the corresponding mutations at the conserved residues of the yeast Shy1 protein, yielding G137E,
F249T, and Y344D mutations (Fig. 1). Expression of the G137E
Shy1 mutant in shy1⌬ cells in two distinct genetic backgrounds
(BY4743 and W303) resulted in a CcO deficiency that precluded growth on nonfermentable carbon sources (Fig. 1C). In
contrast, the respiratory deficiency of shy1⌬ cells in the W303
and BY4743 backgrounds was reversed by the introduction of
vector-borne SHY1 with F249T and Y344D codon mutations,
although BY4743 mutant cells with the Y344D Shy1 mutant
were partially impaired in growth on glycerol-lactate medium
(Fig. 1C). None of the mutant Shy1 proteins had any dominant
negative effects when expressed in wild-type cells (data not
shown). The three mutant Shy1 proteins were stably expressed,
although the G137E mutant protein was partially attenuated in
abundance (Fig. 2A). Cells harboring the F249T and Y344D
mutant Shy1 proteins exhibited near-normal oxygen consumption (data not shown) and CcO activity (Fig. 1D). In contrast,
cells expressing the G137E Shy1 mutant showed low CcO activity (Fig. 1D) and low oxygen consumption (data not shown),
consistent with the lack of growth on glycerol-lactate medium.
Furthermore, G137E Shy1-containing cells showed reduced
steady-state Cox2 levels (Fig. 2A). In line with these data,
BN-PAGE analysis showed that shy1⌬ cells expressing the
G137E Shy1 mutant as well as the vector control cells lacked
the bc1:CcO supercomplex, yet the dimeric bc1 complex was
normal (Fig. 2B). Cells expressing either the F249T or Y344D
Shy1 mutant showed no major difference in supercomplex formation compared to wild-type cells grown at either 30°C or a
more stringent 37°C (Fig. 2B and data not shown).
As mentioned, Shy1 mediates formation of the heme a3:CuB
center in Cox1 (18). This function of Shy1 can be assessed
through a hydrogen peroxide assay previously described (19).
Cells depleted of Cox11 or Sco1 stall CcO assembly and lead to
the accumulation of a pro-oxidant intermediate consisting of
Cox1 with reactive heme a3. The hydrogen peroxide sensitivity
is reversed by the subsequent depletion of Shy1 (19). cox11⌬
shy1⌬ double null cells are resistant to hydrogen peroxide
treatment because the heme a3:CuB site is not stably formed.
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FIG. 1. Human SURF1 and yeast Shy1. (A) Alignment of the yeast (Sce) Shy1 and human (Hsp) SURF1 amino acid sequences (ClustalW).
Bars indicate the predicted transmembrane domains. The asterisks indicate identically conserved residues; colons and periods represent similarly
conserved residues. The arrowheads indicate amino acid residues mutated in Leigh syndrome patients. (B) A schematic view of Shy1. Two
predicted transmembrane domains (TM1 and TM2) are indicated along with the IMS (⬃250 residues) and the N (⬃70-residue)- and C
(⬃25-residue)- terminal domains. Marked are the substitutions in Shy1 corresponding to pathogenic mutations in SURF1. OM, outer membrane.
(C) W303 or BY4743 shy1⌬ cells expressing either Myc-tagged wild-type Shy1 or its G137E, F249T, or Y344D mutant derivatives were precultured
in selective media containing 2% raffinose-0.2% glucose, serially diluted, and spotted onto the plates containing 2% glucose or 2% glycerol-2%
lactate as a carbon source. Pictures were taken after 2 days and 4 days of incubation at 30°C, for glucose and glycerol-lactate, respectively.
(D) Mitochondria isolated from the BY4743 transformants mentioned above were assayed (n ⫽ 3) for CcO activity (change in the OD550
[⌬OD550]/min/10 mg protein).

The reintroduction of SHY1 restores hydrogen peroxide sensitivity expected of cox11⌬ cells (Fig. 2D). Introduction of the
F249T and Y344D Shy1 mutants into the cox11⌬ shy1⌬ null
strain restored hydrogen peroxide sensitivity in the cells, consistent with these mutants being nearly wild type in function
(Fig. 2D). In contrast, transformation of the double null cells
with the G137E Shy1 mutant failed to restore hydrogen peroxide sensitivity, consistent with it being a nonfunctional variant
of Shy1.
Shy1-mediated formation of the heme a3:CuB center in Cox1
occurs within a Cox1 assembly intermediate containing Shy1
(18). This complex is visualized on BN-PAGE as an ⬃450-kDa
band (25, 29, 30) (Fig. 2C). This complex was not detected in
cells containing the G137E Shy1 mutant, and cells expressing
the F249T or Y344D Shy1-Myc mutant showed a reduction in
the abundance of this complex compared to wild-type Shy1
(Fig. 2C).
Cells lacking Shy1 have attenuated levels of mitochondrial
copper, and supplementation of the growth medium with exogenous copper yielded a partial reversal of the growth defect
on nonfermentable carbon sources (29). Respiratory growth of
cells expressing the G137E Shy1 mutant was partially restored
by exogenous copper as with the shy1⌬ cells (data not shown).
Similarly, the G137E Shy1 mutant cells showed low mitochondrial copper levels (55% of WT), and the mitochondrial copper

level of shy1⌬ mitochondria was determined to be ⬃50% of
that of the WT. Cells with F249T and Y344D Shy1 mutants
contained 80% and 75% of wild-type mitochondrial copper
levels, respectively. Thus, the Shy1 role in copper homeostasis
is not significantly altered in the F249T and Y344D Shy1 mutant
strains but is with the G137E Shy1 mutant, similarly to shy1⌬
cells.
Suppressors of the G137E Shy1 respiratory defect. Gly137 is
a highly conserved residue in Shy1 proteins from various species, suggesting that it may be important for Shy1 activity. Since
the G137E Shy1 mutant is a nonfunctional variant, we screened
for extragenic allele-specific suppressors of the respiratory defect of the G137E Shy1 mutant to identify additional proteins
that may be relevant for Shy1 function. Yeast cells harboring
the nonfunctional G137E Shy1 mutant were transformed with a
high-copy DNA library, and suppressors of the respiratory
defect were isolated on SC-glycerol-lactate medium. Respiratory growth was confirmed to be dependent on the library
vector by 5-FOA, which resulted in 58 candidates. The vector
expressing the G137E Shy1 mutant was shed as well, showing
that 23 of the candidates were able to grow on glycerol-lactate
without the Shy1 mutant. These candidates were not pursued,
since we expected many of these clones to be vector-encoded
SHY1 or the well-known MSS51 suppressor (6, 27). The remaining candidates required the presence of the mutant SHY1
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FIG. 2. Characterization of the SURF1/Shy1 mutants in yeast. (A) Immunoblot of the mitochondria (30 g) isolated from the BY4743 (BY)
transformants shown in panel C of Fig. 1. Organelles were separated by SDS-PAGE, and steady-state levels of the Cox2, Cyt1, and Cyc1 were
assessed with the respective antibodies. Steady-state levels of the WT Shy1 and the three Shy1 mutants were determined using anti-Myc antibodies.
The levels of Por1 served as a loading control. (B) Purified mitochondria (100 g) were subjected to BN-PAGE. The distribution of respiratory
complexes was analyzed by Western blotting with antibodies against Cox2 and Cyt1. (C) The Shy1 high-molecular-weight complex was assessed
by BN-PAGE as described above for anti-Myc antibodies. The monomeric form of complex V (loading control) was visualized with anti-F1 serum.
(D) BY4741 cox11⌬ shy1⌬ cells, transformed with the episomal vectors expressing wild-type Cox11, Shy1, or the respective mutant forms of the
latter were grown to the mid-exponential phase and incubated with or without indicated concentration of H2O2 for 2 h at 30°C. Serial dilutions
were spotted onto the plates containing 2% glucose and incubated for 36 to 48 h at 30°C.

(G137E) vector for respiratory growth, and library vectors were
isolated and sequenced. Multiple copies of COA2 and COX10
were recovered as suppressors of the respiratory defect (Fig.
3A). Both Coa2 and Cox10 are known CcO assembly factors
and have been indicated as weak suppressors of the shy1⌬ cell
respiratory defect individually on YP-glycerol-lactate (30). The
suppressive activity of either COA2 or COX10 in shy1⌬ cells is
enhanced in the presence of the G137E Shy1 variant when
grown on YP- or SC-glycerol-lactate.
An additional suppressor candidate was determined to contain a library plasmid, encoding the YLR218c ORF that we
designated COA4 (cytochrome oxidase assembly 4) (Fig. 3A).
Expression of this gene alone does not suppress the respiratory
defect of shy1⌬ cells; however, in the presence of the G137E

Shy1 allele, growth is observed on YP-glycerol-lactate (Fig.
3A). In a recent systematic analysis of yeast proteins with a
conserved twin CX9C motif, Coa4 (Cmc3) was identified and
shown to be a mitochondrial IMS protein (23) (Fig. 3B). This
motif is common to a group of IMS-localized proteins, several
of which are involved in CcO assembly (20).
Coa4 is important for CcO assembly. To confirm the IMS
localization of Coa4 (23), we tested the mitochondrial localization of a vector-borne Myc-tagged Coa4 allele in
coa4⌬ cells (Fig. 4). Coa4 was found to be predominantly
associated with gradient-purified mitochondria (Fig. 4A)
and to be associated with the membrane fraction regardless
of high-salt washes (Fig. 4B). The protein was solubilized by
sodium carbonate washing and degraded by proteinase K in
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FIG. 3. High-copy-number suppressor for the G137E Shy1 respiratory defect. (A) BY4743 shy1⌬ cells transformed with episomal vectors
containing COA4, COA2, and COX10 with or without SHY1 (G137E mutant) were precultured, serially diluted, and analyzed as described in the
legend to Fig. 1C. (B) Amino acid sequence alignment of Coa4 from different eukaryotic organisms (Kluyveromyces lactis, Candida glabrata,
Schizosaccharomyces pombe, Mus musculus, and Homo sapiens). The conserved twin CX9C motif is indicated.

FIG. 4. Localization and topology of Coa4. (A) BY4743 coa4⌬
cells expressing COA4-Myc were lysed and fractionated. Cytosolic and
mitochondrial fractions were subjected to SDS-PAGE and analyzed by
immunoblotting with anti-Myc, anti-Por1, and anti-Pgk1 antibodies. T,
total cell lysate; C, cytosolic fraction; M, mitochondrial fraction.
(B) Isolated organelles were resuspended in 20 mM HEPES (pH 7.4)
and NaCl of the indicated concentrations and sonicated. The soluble
and insoluble fractions were fractionated and analyzed by immunoblotting with anti-Myc, anti-Sod2, and anti-Cyt1 antibodies. (C) Purified mitochondria (50 g) were incubated on ice for 30 min with 20
mM HEPES (pH 7.4) for swelling or with 0.1 M sodium bicarbonate
(pH 11.5) for carbonate extraction (ext.) in the presence of 2 mM
PMSF (phenylmethylsulfonyl fluoride). Following incubation, the soluble and insoluble fractions were separated by high-velocity centrifugation and analyzed by immunoblotting. The soluble matrix protein
Sod2 and integral membrane protein Cox2 were detected with the
respective antibodies. T, total mitochondria; S, supernatant; P, pellet;
ext., extraction. (D) Intact (SW⫺) or osmotically shocked mitochondria (SW⫹) were incubated with (PK⫹) or without (PK⫺) 0.1 mg/ml
of proteinase K (PK) for 30 min on ice. Followed centrifugation, the
treated organelles were separated by SDS-PAGE and analyzed by
immunoblotting with anti-Myc, anti-Cyb2, and anti-Aco1.

isolated mitoplasts (Fig. 4C and D). These results confirm
the IMS localization of Coa4 and identify an association
with the IM. This is consistent with Coa4 lacking any predicted transmembrane helices.
Cells lacking Coa4 in the BY4743 background exhibit a
respiratory defect when plated on SC-glycerol-lactate medium
at room temperature, but the growth defect was less pronounced at elevated temperatures (Fig. 5A and 6A) (23). No
marked growth defect was observed for coa4⌬ cells with the
W303 background at 23 or 30°C (data not shown), yet CcO
activity was depressed to ⬃50% of wild-type activity in this
background (Fig. 5B). CcO activity in coa4⌬ cells in the
BY4743 background was reduced to ⬃40% of that of the wild
type (Fig. 5B). Yeast typically propagate well on glycerol-lactate medium at 30°C when CcO activity is ⬎40% of that of the
wild type. The bc1 reductase activity was unchanged in mutant
cells of either background (Fig. 5B and data not shown). Consistent with the attenuated CcO activity, the steady-state levels
of Cox1, Cox2, and Cox3 were reduced in the coa4 null mutant
(Fig. 5C). The abundance of the bc1:CcO supercomplex was
also markedly diminished (Fig. 5D) without any change in the
ATP synthase monomeric or dimeric complexes. Solubilization
of the IM with dodecyl maltoside further confirmed the attenuated levels of CcO (Fig. 5D). Although Coa4 appears to have
a role in the assembly or stability of the CcO complex, it is not
associated with the CcO supercomplex (Fig. 5G), as Coa4
fractionates in low-mass fractions upon sucrose gradient centrifugation.
Deletions of genes encoding CcO assembly factors often
lead to diminished Cox1 translation by trapping Mss51 in Cox1
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FIG. 5. Cells lacking Coa4 have compromised respiratory functions. (A) Respiratory growth of BY4743 wild-type and coa4⌬ cells was analyzed
as described in the legend to Fig. 1, except that the plates were incubated at room temperature for 3 days. (B) Mitochondria isolated from the
coa4⌬ cells cultured at 30°C were used to determine CcO and SDH/bc1 activities. Enzymatic activities are shown as a percentage of wild-type
specific activity. The data represent an average of three independent repeats, and the error bars indicate one standard deviation (SD).
(C) Mitochondria from WT and coa4⌬ BY4743 cells were separated on SDS-PAGE gels, and the steady-state levels of Cox1, Cox2, Cox3, and Rip1
were assessed by immunoblotting. Por1 served as a loading control. (D) Isolated mitochondria (75 g) were lysed with either 1% digitonin or
DDM. Clarified lysates were subjected to BN-PAGE, and separated protein complexes were analyzed by Western blotting. Anti-Cox2 and
anti-Rip1 antibodies were used to detect complex IV and III, respectively. Anti-F1 was used for detection of complex V. (E) In vivo labeling of
mitochondrial translation products in wild-type, coa4⌬, and shy1⌬ cells and coa4⌬ shy1⌬ double null cells of W303 background. (F) Mitochondria
purified from DY5113 SHY1::13Myc wild-type or coa4⌬ cells were solubilized with 1% digitonin and analyzed by BN-PAGE as described in the
legend to Fig. 2C. V, complex V. (G) Mitochondria from BY4743 coa4⌬ cells transformed with an episomal vector expressing Coa4-13Myc were
loaded onto a continuous 7 to 30% sucrose gradient and subjected to ultracentrifugation (148,000 ⫻ g, 8 h, 2°C). Eighteen fractions were collected,
separated on SDS-PAGE, and analyzed by immunoblotting with antisera to Por1, Cox2, and Myc to detect Coa4-Myc.

preassembly complexes (6). In vivo radiolabeling of mitochondrial translation products revealed that normal levels of Cox1
were synthesized during the pulse and short-chase phase of the
translation assay (Fig. 5E), suggesting that coa4⌬ cells are not
subjected to the downregulation of the Cox1 synthesis seen for
shy1⌬ cells and several CcO assembly mutants (6). Deletion of
COA4 in a shy1⌬ background retains the attenuated level of
Cox1 synthesis seen with shy1⌬ cells. Thus, Coa4 is downstream of the Shy1 effect on Cox1 synthesis. To confirm that
the Cox1 assembly intermediates, including those stabilized by
Mss51 and Shy1 are normal in coa4⌬ cells, we performed
BN-PAGE on Myc epitope-tagged Shy1 (Fig. 5F). The levels
of abundance of the high-mass Shy1-Cox1 complex were similar in wild-type and coa4⌬ cells, substantiating the conclusion
that Cox1 synthesis and early maturation steps are normal in
the mutant cells. Furthermore, no interaction was observed

between Coa4 and Shy1 by direct coimmunoprecipitation (data
not shown).
Since shy1⌬ cells are impaired in mitochondrial copper, we
quantified the copper content of mitochondria from coa4⌬
cells. Mitochondrial copper was reduced to 50% of wild-type
levels in both shy1⌬ and coa4⌬ cells (data not shown), but
supplemental copper failed to enhance the respiratory deficiency of coa4⌬ cells.
Genetic suppression of the coa4⌬ respiratory growth defect.
As mentioned, the respiratory deficiency of shy1⌬ cells can be
suppressed by high-copy-number MSS51, COA1, COA2, or
COX10 (29). We tested whether overexpression of these genes
would enhance the respiratory growth of coa4⌬ cells. No
marked improvement in respiratory growth was observed with
the overexpression of any of these genes (data not shown),
including the COX10 mutant encoding the N196K allele (7), all
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FIG. 6. Overexpression of cytochrome c suppresses the respiratory defect in coa4⌬ cells. (A) Respiratory growth of the BY4743 wild-type and
coa4⌬ cells transformed with episomal vectors expressing CYC1 or CYC7 was analyzed as described in the legend to Fig. 5A. RT, room
temperature. (B) Mitochondria purified from the aforementioned transformants were used to measure CcO and SDH/bc1 enzymatic activities as
described in the legend to Fig. 5B. (C) BN-PAGE analysis of the respiratory complexes as previously described in the legend to Fig. 2.
(D) Steady-state levels of Cox1, Cyc1, and Cyt1 analyzed by immunoblotting. (E) Isolated mitochondria (75 g) were separated by SDS-PAGE
and subjected to the in-gel heme staining. A total of 1 g of horse heart cytochrome c (Cyth) served as a control. Coomassie staining was used to
show that the same amount of the total mitochondrial protein is loaded.

of which are involved in the early assembly stages of Cox1
maturation. This further implies, along with the in vivo translation data, that Coa4 is important in the assembly of CcO
after the maturation of Cox1.
To identify a high-copy-number suppressor that restores respiratory growth of coa4⌬ cells, we transformed a high-copynumber DNA library into the null strain and recovered respiratory-competent clones from 56,000 transformants. Twenty
clones contained a DNA fragment encompassing the gene
CYC1 encoding the soluble electron carrier cytochrome c.
CYC1 as well as CYC7 were subcloned into pRS425 and transformed into coa4⌬ cells. Cyc1 is the dominant cytochrome c
present in aerobic yeast, whereas Cyc7 is an isoform expressed
in hypoxic cells (11). Overexpression of either Cyc1 or Cyc7 in
coa4⌬ cells restored respiratory growth at room temperature
and 30°C (Fig. 6A), as well as CcO activity (Fig. 6B). Restoration of the CcO:bc1 supercomplexes was also observed with
overexpression of CYC1 or CYC7 in coa4⌬ cells (Fig. 6C).
Cytochrome c is known to be important for the assembly and
stability of CcO in yeast and mammals (5, 44), although the

mechanism remains to be elucidated. To assess whether Cyc1
is deficient in coa4⌬ cells, mitochondria isolated from wildtype and coa4⌬ cells were subjected to SDS-PAGE for immunoblot analysis and heme staining. Cyc1 protein levels were
found to be normal in coa4⌬ cells by immunoblotting (Fig.
6D). In addition, heme staining revealed similar levels of
hemylated Cyc1 (Fig. 6E) as well as Cyt1, which is a component of the bc1 complex (data not shown).
Cyc1 suppression of coa4⌬ cells. The suppressor activity of
Cyc1 in coa4⌬ cells may arise from impaired binding to Cox2
within the CcO complex. Near the interface where Cyc1 docks
on Cox2 lies the Cox12 subunit that contains a twin CX9C
motif analogous to Coa4. Since cox12 mutant cells have impaired CcO activity (21), we questioned whether Cox12 insertion into CcO was impaired in coa4⌬ cells. Overexpression of
COX12 failed to restore respiratory growth in coa4⌬ cells (data
not shown).
Cyc1 binding to Cox2 is mediated by electrostatic interactions arising from a constellation of basic residues on Cyc1 and
carboxylates on Cox2 (26). In the interaction of Cyc1 and the
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FIG. 7. Charge reversal mutations in cytochrome c retain residual suppressor activity for coa4⌬ cells but not cyc1⌬ cyc7⌬ mutant cells.
(A) Respiratory growth of the BY4743 wild-type and coa4⌬ cells transformed with episomal vectors expressing wild-type and mutant forms of
CYC1 or wild-type CYC7 was analyzed as described in the legend to Fig. 1. (B) Respiratory growth of the BY4743 wild-type and shy1⌬ cells
transformed with episomal vectors expressing wild-type CYC1 and CYC7. (C) Expression of the wild-type and mutant forms of Cyc1 in whole-cell
extracts assessed by immunoblotting. Whole-cell proteins were precipitated with 20% trichloroacetic acid (TCA) and resolved on 15% SDS-PAGE.
Pgk1 was used as a loading control.

bc1 complex, oppositely charged residue pairs contribute to
long-range coulombic interactions (34). A series of Lys3Glu
charge reversal mutations were engineered in Cyc1 to test
whether attenuation in this interaction alters the suppressor
activity of Cyc1. Two different double mutants carrying K78E
K79E and K92E K93E and a quadruple mutant containing the
four Lys3Glu substitutions were tested for suppressor activity
in coa4⌬ cells as well as Cyc1 function in cyc1⌬ cyc7⌬ double
null cells (Fig. 7A). Addition of the quad Cyc1 mutant to the
cyc1⌬ cyc7⌬ double mutant failed to restore respiratory
growth, but suppressor activity in coa4⌬ cells was only partially
impaired (Fig. 7A). The different Cyc1 mutants were all expressed as stable proteins and could be observed by steadystate immunoblotting (Fig. 7C). Expression of a second Cyc1
mutant (the W65S mutant) that impairs Cyc1 function (5, 44) in
coa4⌬ cells failed to restore respiratory growth (data not
shown), although interpretation of this result is complicated by
the reported inefficient mitochondrial import of this mutant
protein (5, 44). Whereas Cyc1 and Cyc7 were efficient suppressors of the respiratory defect of coa4⌬ cells, neither protein
alone upon overexpression facilitated respiratory growth of the
Shy1 G137E mutant cells (Fig. 7B).
To gain insights into the mechanism by which Cyc1 restores
CcO function in coa4⌬ cells, we sought to investigate the
membrane association of Cyc1 and stability of CcO in WT
versus coa4⌬ cells. Cyc1 is associated with the inner membrane
by forming transient encounter complexes with bc1 and CcO,
primarily by electrostatic interactions in addition to hydrophobic contacts with the lipid bilayer that involve cardiolipin (36,
42, 43). First, mitoplasts isolated from each cell were treated
with increasing salt concentrations or proteinase K, and membrane association of Cyc1 was assessed by immunoblotting
(Fig. 8A). High salt is known to partially dissociate Cyc1 from
mitochondrial membranes. Cyc1 membrane association is attenuated in coa4⌬ cells relative to WT cells in a salt-dependent
fashion (Fig. 8A, top strips). Since the diminution in CcO may
contribute to the observed salt-dependent loss of membraneassociated Cyc1 in cells lacking Coa4, we also compared the
membrane association of Cyc1 in two other CcO mutants that

lack any assembled CcO (Fig. 8B). Cells lacking Cox11 or
Cox19 fail to assemble any CcO complex and yet retain appreciable Cyc1 levels in mitoplasts treated with 0.5 M NaCl, unlike
coa4⌬ cells. Second, mitoplasts were also treated with proteinase K to assess the stability of CcO in WT and coa4⌬ cells in
the BY4743 background. The addition of proteinase K led to a
greater diminution in Cox1 and Cox2 in the mutant cells relative to WT cells. The apparent proteolytic instability of CcO
in mutant cells may arise from an effect of Coa4 on complex IV
stability or from the destabilization of bc1:CcO supercomplexes. However, the attenuation in membrane association of
Cyc1 in coa4⌬ cells suggests that Coa4 may have a role in the
membrane stabilization of Cyc1, which is likely important for
its additional role in CcO assembly.
DISCUSSION
Studies of three missense SURF1 mutations identified in
patients with LS were evaluated with the yeast Shy1 protein.
The G137E substitution in Shy1 results in a nonfunctional protein conferring a CcO deficiency. The G137E Shy1 mutation
also recapitulates other SHY1 deletion phenotypes, including
inefficient heme a insertion and low mitochondrial copper. The
inefficient heme a insertion activity likely arises from the destabilization of the ⬃450-kDa Shy1/Cox1 assembly intermediate. The lack of a robust CcO deficiency of the F249T and
Y344D mutations suggests that the human protein is less tolerant of variations than the yeast protein. Although the F249T
Shy1 mutant shows near normal CcO assembly in yeast, the
steady-state levels of the Shy1/Cox1 assembly intermediate are
partially attenuated. This attenuation of the complex may have
a more significant impact on CcO assembly in human LS patients.
The loss of function in the G137E Shy1 mutant created an
opportunity for a genetic suppressor screen focusing on allelespecific suppressors that would shed further insights on the
Shy1 function in CcO biogenesis and potentially provide information on protein interactions. An abnormal protein can at
times be restored to greater functionality by changes in an
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FIG. 8. Association of cytochrome c with the inner mitochondrial
membrane and CcO stability are decreased in coa4⌬ mitochondria.
(A) Mitochondria isolated from wild-type and coa4⌬ cells were osmotically shocked (SW⫹) or left intact (SW⫺). Swollen mitochondria
were incubated with NaCl at indicated concentrations for 20 min on
ice. Then, all samples were incubated with or without PK as described
in the legend to Fig. 4D. Following the incubations, organelles were
fractionated, and obtained pellets subjected to SDS-PAGE and analyzed by Western blotting using antisera against Cyc1, Cox1, Cox2,
Cox3, and Cox4. Note that the exposure time for the immunoblots with
coa4⌬ cells was longer due to the reduced steady-state levels of CcO
subunits. (B) Mitochondria (50 g) from BY4743 wild-type, coa4⌬,
cox11⌬, and cox19⌬ cells were treated as described above and subjected to SDS-PAGE followed by immunoblotting with anti-Cyc1 and
anti-Aco1. The bar graph showing the abundances of the membranebound Cyc1, retained after the salt treatment of wild-type, coa4⌬,
cox11⌬, or cox19⌬ mitoplasts. Quantifications were done using Image
J software; the error bars indicate SD; n ⫽ 2.

interacting partner. Presently, COA2, COA4, and COX10 were
found to be allelic suppressors of the G137E Shy1 mutant.
Coa4 is a newly identified CcO assembly factor. Its initial
characterization was recently reported in a comprehensive
study of the 14 twin CX9C motif proteins in yeast (23). As with
the other twin CX9C proteins, Coa4 is an IMS protein whose
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import is dependent on the Mia40 machinery (23). Cells lacking Coa4 in two distinct genetic backgrounds have reduced
CcO activity and steady-state protein levels but do not show a
reproducible change in the bc1 complex. The respiratory defect
is most pronounced at room temperature and minimal at 37°C.
Mitochondrial translation of Cox1-Cox3 appears normal in
coa4⌬ cells. Many CcO assembly mutants are impaired in Cox1
synthesis, but coa4⌬ cells do not fall into that group. This is
consistent with the lack of significant suppression of the respiratory defect by overexpression of MSS51 or other factors
(COX10 and COA1) that stabilize newly synthesized Cox1. In
addition, the Shy1/Cox1 assembly intermediate is wild type
in coa4⌬ cells. Thus, the CcO assembly/stability impairment in
coa4⌬ cells is not related to a defect in Cox1 maturation. No
interaction of Coa4 and Shy1 or the bc1:CcO supercomplex
was evident.
Cells lacking Coa4 resemble shy1⌬ cells in exhibiting a reduced mitochondrial copper content. The matrix copper content was similarly reduced in these deletion strains as well as
coa1⌬ cells (⬃50% of that of the wild type). Whereas copper
supplementation enhanced respiratory growth of coa1⌬ and
shy1⌬ cells, it was less effective in promoting respiratory
growth of coa4⌬ cells. We postulated previously that Coa1 and
Shy1 may, in addition to their roles in Cox1 maturation, modulate Cu(I) import into the matrix or export to the IMS for
CcO biogenesis (29). Coa4 may likewise be part of the Cu(I)
routing pathway.
A major clue to the function of Coa4 was the isolation of
Cyc1 as an extragenic suppressor of the respiratory defect of
coa4⌬ cells. Cyc1 is important for the assembly and/or stability
of CcO (5, 44), and this is the first time that Cyc1 has been
found as a suppressor of a CcO mutant. High-copy-number
CYC1 is an efficient suppressor of coa4⌬ cells but not Shy1
G137E mutant cells. Elevated Cyc1 was effective despite the
lack of diminution in chromosomally encoded Cyc1 levels in
coa4⌬ cells. The suppressor activity of Cyc1 was attenuated but
not eliminated by a quadruple Cyc1 mutant with four Lys3Glu
substitutions in the docking pocket that affects interactions
with Cox2. However, quadruple mutant Cyc1 fails to support
respiratory growth in cells lacking WT Cyc1 and Cyc7.
The basis for the suppression of the coa4⌬ cell respiratory
phenotype by elevated Cyc1 may relate to an observed decrease in membrane association of Cyc1. Membrane association of Cyc1 occurs by electrostatic interactions of encounter
complexes with bc1, CcO, and the lipid bilayer as well as hydrophobic effects with the bilayer (36, 42, 43). Cardiolipin
contributes to the membrane anchoring of Cyc1 (36). The
observed suppressive effect by Cyc1 may indicate that the phospholipid domain encompassing CcO is altered in composition
in coa4⌬ cells. Alternatively, other membrane proteins have
been suggested to mediate the membrane association of Cyc1
with CcO (35). Either membrane lipid composition or a putative protein mediating Cyc1 docking may contribute to the
known role of Cyc1 in CcO biogenesis and/or stability. There is
no indication that Coa4 contributes directly to binding Cyc1, as
no coimmunoprecipitation was observed between these two
proteins. The attenuated CcO observed in coa4⌬ cells, therefore, may arise from impaired stability of the complex that
could have a marked impact on supercomplexes with bc1. Cardiolipin is important for Cyc1 membrane association as well as
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supercomplex formation, so if Coa4 had a role in the membrane lipid composition, the observed phenotypes of attenuated CcO and Cyc1 membrane association may be explained.
Future studies will address whether Coa4 affects the membrane lipid composition of the IM in a way that would be
important for CcO assembly.
In addition to COA4, COA2 and COX10 were also found to
be allelic suppressors of the G137E Shy1 mutant. COA2 and
COX10 were shown previously to be weak suppressors of the
shy1⌬ respiratory defect (30). Their suppression activity is enhanced by the presence of the G137E Shy1 mutant. Coa2 appears to have a role concurrent with Shy1 in the assembly of
the CuB:heme a3 redox center (7). Although Coa2 and Shy1
transiently interact (30), the mechanism of suppression by
Coa2 of the G137E Shy1 mutant is unclear. Coa2 is membrane
associated on the matrix side of the IM, whereas the Gly137
residue exists within the IMS domain of Shy1. Since the G137E
Shy1 mutant fails to stably form the ⬃450-kDa Cox1 assembly
intermediate visualized by BN-PAGE, high levels of Coa2 may
enhance respiratory growth by stabilizing this important assembly intermediate, permitting CuB:heme a3 site formation.
Alternatively, the G137E Shy1 mutant may stabilize Coa2, enhancing its Cox1 chaperone activity.
The allelic suppression by COX10 may occur somewhat differently, as no evidence exists for a physical interaction between Cox10 and Shy1. Cox10 functions in the first step in
heme a biosynthesis and Shy1 functions in the hemylation of
Cox1, so the intersection of Cox10 and Shy1 is rational. High
levels of Cox10 may enhance the hemylation of Cox1 that may
be compromised in the G137E Shy1 mutant cells. The catalytic
function of Cox10 appears linked to its homo-oligomerization
(7). We demonstrated that a N196K substitution in Cox10 bypassed the inefficient hemylation of Cox1 in cells lacking Coa2
through enhanced stability of the Cox10 oligomer (7). The
G137E Shy1 mutant may likewise contribute in some way to
Cox10 oligomerization, a process that is markedly impaired in
shy1⌬ cells. Another potential mechanism may relate to the
recent observation that bacterial Surf1 is a heme-binding protein (10). An H193A Surf1 mutant had reduced heme binding.
Mutations of either of the two conserved His residues (H141
and H341) in yeast Shy1 resulted in no defect in Shy1 function,
and cells harboring a double His substitution showed only a
modest growth impairment on glycerol-lactate (data not
shown). Thus, it is unlikely that the G137E Shy1 suppression by
Cox10 relates to heme binding to Shy1.
In summary, characterization and allelic suppresion studies
of the Shy1 G137E mutation have led to a better understanding
of the CcO assembly pathway and the factors involved in this
process. A novel assembly factor, Coa4, was identified through
these studies and found to be genetically linked to the CcO
assembly function of Cyc1.
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